Search

You searched for "haemoglobin"

29 results found

A new haemostatic agent in tubeless PCNL

1 March 2014 | | Endourology and Stones
Tubeless percutaneous nephrolithotomy (PCNL) is increasingly being used in carefully selected patients to reduce hospital stay and analgesia requirements, especially in those with little bleeding who become stone free or have insignificant residual fragments (usually <4mm). Various agents have been...

Technology – Part 2

1 November 2014 | | Andrology, Basic Science Research, Endourology and Stones, Functional Urology, Infection, Neurourology, Paediatric Urology, Technological Developments, Trauma and Emergency Urology, Urologic Oncology, Uroradiology
Case 1 Name the machine shown in the picture and describe how it works. What is the standard frequency of ultrasound waves in this machine? What frequency of ultrasound waves are utilised in an abdominal and scrotal ultrasound? Case 2...

Predictors of vaginal mesh exposure after mid-urethral sling placement

1 March 2017 | | Functional Urology, Infection | Bariatric surgery, Complication, Midurethral sling, Vaginal exposure
Vaginal mesh exposure following mid-urethral sling (MUS) insertion can be a difficult complication to treat. The aim of this study was to identify possible risk factors in patients who had unfortunately developed vaginal mesh exposure following MUS surgery. This was...

Comparison of PCNL under spinal versus general anaesthesia

1 May 2014 | | Endourology and Stones
There are several advantages of performing percutaneous nephrolithotomy (PCNL) under spinal anaesthesia including lower cost, reduced adverse effects and less tracheal tube displacement. Another advantage is that the patient remains awake throughout making positioning easier and reducing the risk of...

Transurethral enucleation is superior to resection for the management of LUTS secondary to BPH

7 July 2020 | | Endourology and Stones
This meta-analysis (Level 1b evidence) examined the efficacy and safety of two primary transurethral therapies used in the management of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), enucleation (HoLEP – holmium laser enucleation of prostate, ThuLEP,...

Priapism in sickle cell disease

2 March 2022 | | Andrology
What is sickle cell disease? Sickle cell disease (SCD) is one of the most common single-gene disorders in the UK affecting approximately one in every 2000 live births. Approximately 20-25 million people worldwide have SCD. It predominately affects those of...

Sepsis syndrome in urology

1 November 2015 | | Infection
There are approximately 100,000 cases of sepsis per year in the UK, of which 37,000 result in death (this is more than prostate cancer, breast cancer, HIV / AIDS and road traffic accidents combined). Urosepsis is defined as sepsis caused...

An algorithm for the management of haemorrhagic cystitis

1 September 2015 | | Endourology and Stones, Functional Urology, Urologic Oncology
Haemorrhagic cystitis (HC) can be one of the most difficult conditions to treat in urological practice. It is characterised by intractable bleeding from the bladder and may be acute or chronic. The most frequently reported causal factors are radiotherapy (RT)...

Demanding cases or nightmares in endourology? Sep/Oct 2015

1 September 2015 | | Endourology and Stones
One of the most interesting aspects of attending international meetings is the rare but invaluable, honest presentation of complex cases. We aim to present the readers with some complex and challenging ongoing cases in endourology. Case 1 A general practitioner...

The 10 commandments of laparoscopic urology

1 March 2015 |
Laparoscopic urologic procedures continue to attract the interest of trainees, consultants and the public, and the demand for training is on the increase [1,2,3]. The vast majority of laparoscopic procedures are laparoscopic nephrectomies and this is certainly the most common...

Lasers in benign prostatic hyperplasia

1 January 2014 | | Functional Urology, Technological Developments
Clinical benign prostatic hyperplasia (BPH) impacts on the quality of life of many men. It is intimately related to ageing, but exact calculations of its prevalence remain difficult since an accurate clinical definition still eludes us. Histological BPH has been...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | Functional Urology, Infection, Neurourology, Technological Developments
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...
  • 1 (current)
  • 2
  • 3